Market Capitalization (Millions $) |
- |
Shares
Outstanding (Millions) |
44 |
Employees |
- |
Revenues (TTM) (Millions $) |
8 |
Net Income (TTM) (Millions $) |
-23 |
Cash Flow (TTM) (Millions $) |
12 |
Capital Exp. (TTM) (Millions $) |
0 |
Clarus Therapeutics Holdings Inc.
Clarus Therapeutics Holdings Inc. is a pharmaceutical company focused on the development and commercialization of innovative therapies for men's health and endocrine disorders. The company specializes in the development of oral, small molecule drugs and is committed to addressing unmet medical needs in areas such as testosterone replacement therapy, hypogonadism, and other hormone-related conditions. Clarus Therapeutics aims to improve the quality of life for patients through its research, development, and marketing efforts.
Company Address: 555 Skokie Boulevard Northbrook 60062 IL
Company Phone Number: 562-4300 Stock Exchange / Ticker: NASDAQ CRXT
|